Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: GSK, Neogap, Novo Nordisk, Ose, Scynexis, Veru, Virpax.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Beigene, I-Mab, Novaliq, Pharmacyclics, Senju, Tracon.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Highfield, Mabwell, Nanjing Leads Biolabs, Takeda, TG.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bavarian Nordic, Innocare, Mindrank AI, Olix, Takeda, Tessa.

Biopharmas in Asia-Pacific raising money in public or private financings: Metagen.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Avita, Everest.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: F2G, Freya, Iaso, Sirnaomics, SK.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Axial, Boehringer Ingelheim, Celly, Codiak, CSL, Emergex, Evox, FSD, M42, Neural, NMD, Pharmather, Regenxbio, Sanofi, Sarepta, Sequantix, Sumitomo, Thermosome, Uniqure, Vertical Peak, Vitruvias.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allgenesis, Ascendis, BMS, Bone, Chinook, Eli Lilly, Horizon, Kancera, Mirati, Molecular Targeting, Rhythm, Sensorion, Seres, Telix, Ultimovacs, Vera.

Biopharmas raising money in public or private financings, including: Idorsia, Pharvaris, Turbine.